In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma

Current Oncology

Volumn 23, Issue , 2016, Pages S15-S22

  Fisher, T ^a   Golan, H ^a,b   Schiby, G ^c   Prichen, S ^d   Smoum, R ^e   Moshe, I ^a   Peshes Yaloz, N ^d   Castiel, A ^d   Waldman, D ^a,b   Gallily, R ^e   Mechoulam, R ^e   Toren, A ^a,f  

^a Cancer Research Center   (Israel)

^b Department of Pediatric Hemato Oncology   (Israel)

^c Department of Pathology ^*  (Israel)

^d SHEBA MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Cannabidiol; Neuroblastoma; Non psychoactive cannabinoids; Tumour xenograft models; 9 tetrahydrocannabinol

Indexed keywords

CANNABIDIOL; CASPASE 3; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANNEXIN V ASSAY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CASPASE ASSAY; CELL CULTURE; CELL CYCLE; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; HISTOLOGY; HUMAN; HUMAN CELL; MICROSCOPY; MOUSE; MTT ASSAY; NEUROBLASTOMA; NONHUMAN; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING;

EID: 84961647327     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.23.2893     Document Type: Article

References (50)

1. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369:2106-20.
2. London WB, Castel V, Monclair T, et al. Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project. J Clin Oncol 2011;29:3286-92.
3. Mechoulam R, ed. The Pharmacohistory of Cannabis sativa Cannabinoids as Therapeutic Agents. Boca Raton, FL: CRC Press; 1986:1-19.
4. Pertwee RG. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 2009;156:397-411.
5. Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M, Guzman M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 2000;6:313-19.
6. Velasco G, Sanchez C, Guzman M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer 2012;12:436-44.
7. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999;400:452-7.
8. O’Sullivan SE. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. Br J Pharmacol 2007;152:576-82.
9. Galanti G, Fisher T, Kventsel I, et al. Delta9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of e2f1 in human glioblastoma multiforme cells. Acta Oncol 2008;47:1062-70.
10. Carracedo A, Lorente M, Egia A, et al. The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 2006;9:301-12.
11. Calvaruso G, Pellerito O, Notaro A, Giuliano M. Cannabinoidassociated cell death mechanisms in tumor models (review). Int J Oncol 2012;41:407-13.
12. Salazar M, Carracedo A, Salanueva IJ, et al. Cannabinoid action induces autophagy-mediated cell death through stimulation of er stress in human glioma cells. J Clin Invest 2009;119:1359-72.
13. Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of ampk-dependent activation of autophagy. Cell Death Differ 2011;18:1099-111.
14. Portella G, Laezza C, Laccetti P, De Petrocellis L, Di Marzo V, Bifulco M. Inhibitory effects of cannabinoid cb1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis. FASEB J 2003;17:1771-3.
15. Qamri Z, Preet A, Nasser MW, et al. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther 2009;8:3117-29.
16. Ramer R, Hinz B. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 2008;100:59-69.
17. McAllister SD, Murase R, Christian RT, et al. Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis. Breast Cancer Res Treat 2011;129:37-47.
18. Massi P, Solinas M, Cinquina V, Parolaro D. Cannabidiol as potential anti-cancer drug. Br J Clin Pharmacol 2012;75:303-12.
19. Gomez del Pulgar T, Velasco G, Sanchez C, Haro A, Guzman M. De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis. Biochem J 2002;363:183-8.
20. Ellert-Miklaszewska A, Kaminska B, Konarska L. Cannabinoids down-regulate pi3k/Akt and erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 2005;17:25-37.
21. Blazquez C, Salazar M, Carracedo A, et al. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression. Cancer Res 2008;68:1945-52.
22. Blazquez C, Gonzalez-Feria L, Alvarez L, Haro A, Casanova ML, Guzman M. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 2004;64:5617-23.
23. Oesch S, Walter D, Wachtel M, et al. Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma. Mol Cancer Ther 2009;8:1838-45.
24. Notaro A, Sabella S, Pellerito O, et al. Involvement of par-4 in cannabinoid-dependent sensitization of osteosarcoma cells to trail-induced apoptosis. Int J Biol Sci 2014;10:466-78.
25. Gilbert LC, Wachsman JT. Characterization and partial purification of the plasminogen activator from human neuroblastoma cell line, SK-N-SH. A comparison with human urokinase. Biochim Biophys Acta 1982;704:450-60.
26. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE. Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 1970;30:2110-18.
27. Yeger H, Baumal R, Pawlin G, et al. Phenotypic and molecular characterization of inducible human neuroblastoma cell lines. Differentiation 1988;39:216-27.
28. Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Clin Cancer Res 2005;11:4321-30.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
30. Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H. Cannabinoids for cancer treatment: progress and promise. Cancer Res 2008;68:339-42.
31. Romano B, Borrelli F, Pagano E, Cascio MG, Pertwee RG, Izzo AA. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. Phytomedicine 2014;21:631-9.
32. Nabissi M, Morelli MB, Amantini C, et al. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a trpv2-dependent manner. Int J Cancer 2015;137:1855-69.
33. Morelli MB, Offidani M, Alesiani F, et al. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2. Int J Cancer 2014;134:2534-46.
34. Elbaz M, Nasser MW, Ravi J, et al. Modulation of the tumor microenvironment and inhibition of egf/egfr pathway: novel anti-tumor mechanisms of cannabidiol in breast cancer. Mol Oncol 2015;9:906-19.
35. Ligresti A, Moriello AS, Starowicz K, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 2006;318:1375-87.
36. Ramer R, Merkord J, Rohde H, Hinz B. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem Pharmacol 2010;79:955-66.
37. Ramer R, Rohde A, Merkord J, Rohde H, Hinz B. Decrease of plasminogen activator inhibitor-1 may contribute to the anti-invasive action of cannabidiol on human lung cancer cells. Pharm Res 2010;27:2162-74.
38. Aviello G, Romano B, Borrelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl) 2012;90:925-34.
39. Singer E, Judkins J, Salomonis N, et al. Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma. Cell Death Dis 2015;6:e1601.
40. McAllister SD, Christian RT, Horowitz MP, Garcia A, Desprez PY. Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells. Mol Cancer Ther 2007;6:2921-7.
41. Massi P, Solinas M, Cinquina V, Parolaro D. Cannabidiol as potential anticancer drug. Br J Clin Pharmacol 2013;75:303-12.
42. El Andaloussi-Lilja J, Lundqvist J, Forsby A. trpv1 expression and activity during retinoic acid-induced neuronal differentiation. Neurochem Int 2009;55:768-74.
43. Caballero FJ, Soler-Torronteras R, Lara-Chica M, et al. AM404 inhibits nfat and nf-κb signaling pathways and impairs migration and invasiveness of neuroblastoma cells. Eur J Pharmacol 2015;746:221-32.
44. Louhivuori LM, Bart G, Larsson KP, et al. Differentiation dependent expression of trpa1 and trpm8 channels in IMR-32 human neuroblastoma cells. J Cell Physiol 2009;221:67-74.
45. Cellai I, Benvenuti S, Luciani P, et al. Antineoplastic effects of rosiglitazone and pparγ transactivation in neuroblastoma cells. Br J Cancer 2006;95:879-88.
46. Baek YM, Hwang HJ, Kim SW, et al. A comparative proteomic analysis for capsaicin-induced apoptosis between human hepatocarcinoma (HepG2) and human neuroblastoma (SKN-SH) cells. Proteomics 2008;8:4748-67.
47. Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ. The role of cb1 receptors in psychostimulant addiction. Addict Biol 2008;13:225-38.
48. Hollister LE, Gillespie H. Interactions in man of delta-9-tetrahydrocannabinol. ii. Cannabinol and cannabidiol. Clin Pharmacol Ther 1975;18:80-3.
49. Guzman M, Duarte MJ, Blazquez C, et al. A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer 2006;95:197-203.
50. Holland ML, Lau DT, Allen JD, Arnold JC. The multidrug transporter abcg2 (bcrp) is inhibited by plant-derived cannabinoids. Br J Pharmacol 2007;152:815-24.